Top Biotechnology & Medical Research stocks in Australasia

Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.

Name	Market Cap	Price to Earnings TTM	Dividend Yield % TTM
TLXTelix Pharmaceuticals	AU$5.63bn	250.55	n/a
MSBMesoblast	AU$3.35bn	n/a	n/a
CU6Clarity Pharmaceuticals	AU$1.57bn	n/a	n/a
RACRace Oncology	AU$738.41m	n/a	n/a
PYCPYC Therapeutics	AU$703.71m	n/a	n/a
IMMImmutep	AU$445.42m	n/a	n/a
CGSCogstate	AU$412.18m	27.14	0.83%
DXBDimerix	AU$308.23m	n/a	n/a
TTXTetratherix	AU$257.19m	n/a	n/a
PARParadigm Biopharmaceuticals	AU$155.77m	n/a	n/a
PEBPacific Edge	NZ$158.32m	n/a	n/a
ATHAlterity Therapeutics	AU$109.53m	n/a	n/a
ALAArovella Therapeutics	AU$109.35m	n/a	n/a
ACWActinogen Medical	AU$95.31m	n/a	n/a
LTPLtr Pharma	AU$92.30m	n/a	n/a
BXNBioxyne	AU$84.43m	17.11	n/a
ILAIsland Pharmaceuticals	AU$82.63m	n/a	n/a
IMUImugene	AU$80.95m	n/a	n/a
NYRNyrada	AU$73.82m	n/a	n/a
PIQProteomics International Laboratories	AU$62.96m	n/a	n/a